Beyond Air Inc
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $100.37 million
- Book Value:
- Revenue TTM:
- Operating Margin TTM:
- Gross Profit TTM:
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Beyond Air Inc had its IPO on 2017-09-22 under the ticker symbol XAIR.
The company operates in the Healthcare sector and Medical Devices industry. Beyond Air Inc has a staff strength of 98 employees.
Shares of Beyond Air Inc opened at $3.16 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $3.16 - $3.32, and closed at $3.19.
This is a +0.95% increase from the previous day's closing price.
A total volume of 168,369 shares were traded at the close of the day’s session.
In the last one week, shares of Beyond Air Inc have increased by +0.79%.
Beyond Air Inc's Key Ratios
Beyond Air Inc has a market cap of $100.37 million, indicating a price to book ratio of 2.9451 and a price to sales ratio of 932.7421.
In the last 12-months Beyond Air Inc’s revenue was $59000 with a gross profit of $873190 and an EBITDA of $-55484000. The EBITDA ratio measures Beyond Air Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Beyond Air Inc’s operating margin was -95752.54% while its return on assets stood at -42.81% with a return of equity of -113.68%.
In Q2, Beyond Air Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 52.7%.
Beyond Air Inc’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $-2.09 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Beyond Air Inc’s profitability.
Beyond Air Inc stock is trading at a EV to sales ratio of 630.6116 and a EV to EBITDA ratio of -2.1888. Its price to sales ratio in the trailing 12-months stood at 932.7421.
Beyond Air Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $73.04 million
- Total Liabilities
- $12.02 million
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Beyond Air Inc ended 2023 with $73.04 million in total assets and $0 in total liabilities. Its intangible assets were valued at $73.04 million while shareholder equity stood at $35.46 million.
Beyond Air Inc ended 2023 with $0 in deferred long-term liabilities, $12.02 million in other current liabilities, 3000.00 in common stock, $-193550000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $31.35 million and cash and short-term investments were $56.99 million. The company’s total short-term debt was $877,000 while long-term debt stood at $13.75 million.
Beyond Air Inc’s total current assets stands at $63.36 million while long-term investments were $0 and short-term investments were $25.64 million. Its net receivables were $682000.00 compared to accounts payable of $1.74 million and inventory worth $1.34 million.
In 2023, Beyond Air Inc's operating cash flow was $-9653000.00 while its capital expenditure stood at $795000.
Comparatively, Beyond Air Inc paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Beyond Air Inc stock is currently trading at $3.19 per share. It touched a 52-week high of $9.94 and a 52-week low of $9.94. Analysts tracking the stock have a 12-month average target price of $14.83.
Its 50-day moving average was $3.42 and 200-day moving average was $5.39 The short ratio stood at 6.26 indicating a short percent outstanding of 0%.
Around 1642.5% of the company’s stock are held by insiders while 2076.3% are held by institutions.
Frequently Asked Questions About Beyond Air Inc
Similar Industry Stocks (Medical Devices)
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.